DPYD and fluoropyrimidines: Using the data as our guide
- 31 December 2024
- journal article
- editorial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 44 (12) , 896-897
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- DPYD Testing: Time to Put Patient Safety FirstJournal of Clinical Oncology, 2023
- Assessment of the Clinical Utility of PretreatmentDPYDTesting for Patients Receiving Fluoropyrimidine ChemotherapyJournal of Clinical Oncology, 2022
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 UpdateClinical Pharmacology & Therapeutics, 2017
- Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost AnalysisJournal of Clinical Oncology, 2016